申请人:OSAKA UNIVERSITY
公开号:US10793584B2
公开(公告)日:2020-10-06
In order to provide a naphthobischalcogenadiazole derivative that can be used as an intermediate for producing a naphthobischalcogenadiazole compound into which a fluorine atom has been introduced, the naphthobischalcogenadiazole derivative in accordance with an aspect of the present invention is represented by a formula (I):
where each of A1 and A2 is independently an oxygen atom, a sulfur atom, a selenium atom, or a tellurium atom; and each of X1 and X2 is independently a hydrogen atom, a halogen atom, a boronic acid group, a boronic acid ester group, a boronic acid diaminonaphthalene amide group, an N-methyliminodiacetic acid boronate group, a trifluoroborate salt group, or a triolborate salt group.
为了提供一种萘二异噻二唑衍生物,该衍生物可用作生产引入了氟原子的萘二 异噻二唑化合物的中间体,根据本发明的一个方面,萘二异噻二唑衍生物由式 (I) 表示:
其中,A1 和 A2 各自独立地为氧原子、硫原子、硒原子或碲原子;X1 和 X2 各自独立地为氢原子、卤素原子、硼酸基团、硼酸酯基团、硼酸二氨基萘酰胺基团、N-甲基二乙酸硼酸盐基团、三氟硼酸盐基团或三硼酸盐基团。